Identify compounds in clinical use that are capable of effectively interrupting the spread of SARS-CoV-2 in the body.

SARS-CoV-2 depends on microtubules (set of molecules involved in cellular processes) for its release, therefore, microtubules can be an effective target (therapeutic targets are the place in the body where the drug exerts its action). The world’s largest drug library will be screened for drugs that interrupt microtubule transport and viral replication, analyzing what doses are tolerable.

Principal Investigator: José F. Díaz Pereira (CNB)    

ISCIII COV20_01007     

We use cookies on this site to improve your user experience. More info. ACEPTAR

Aviso de cookies